SCHEMBL2997216

SCHEMBL2997216

COC(=O)CCN1C(=O)c2c(N)sc(-c3ccc(OC)c(OC)c3)c2C1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 3/20 0.42
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
HSD17B10 Q99714 2/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
LMNA P02545 1/20 0.40
PRKCZ Q05513 1/20 0.40
TP53 P04637 1/20 0.40
MDM2 Q00987 1/20 0.40
TNF P01375 3/20 0.38
HDAC1 Q13547 2/20 0.38
HDAC2 Q92769 2/20 0.38
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2994385 0.93 ALDH1A1 (0.42) CASP3ALDH1A1HPGDHSD17B10MAPT
SCHEMBL2995635 0.93 ALDH1A1 (0.42) CASP3ALDH1A1HPGDHSD17B10MAPT
SCHEMBL2998875 0.91 CASP3 (0.38) CASP3ALDH1A1HPGDHSD17B10MAPT
SCHEMBL2996891 0.89 ABCB1 (0.49) CASP3ALDH1A1HPGDHSD17B10MAPT
SCHEMBL2987999 0.89 PDE4B (0.48) POLBPDE4APDE4BPDE4CPDE4D
SCHEMBL2994679 0.82 LMNA (0.44) CASP3ALDH1A1HPGDHSD17B10MAPT
SCHEMBL2985501 0.76 PDE4B (0.43) POLBPDE4APDE4BPDE4CPDE4D
SCHEMBL2999671 0.76 PDE4B (0.42) CASP3ALDH1A1HPGDHSD17B10MAPT
SCHEMBL2993145 0.76 ALDH1A1 (0.42) ALDH1A1HPGDMAPTLMNAPRKCZ
SCHEMBL31564767 0.75 CASP3 (0.43) CASP3LMNATNFPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100179189-A1 PYRROLINE DERIVATIVES AGAINST CELL RELEASING TUMOR NECROSIS FACTOR, PREPARATION METHODS AND USES THEREOF ZHANG HESHENG 2010-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179189-A1 PYRROLINE DERIVATIVES AGAINST CELL RELEASING TUMOR NECROSIS FACTOR, PREPARATION METHODS AND USES THEREOF TNF, IL1B, NOS1 CASP3 19/4885ALDH1A1 1039/4885HPGD 169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.